✦ LIBER ✦

Unique Substrate Specificity of Anaplastic Lymphoma Kinase (ALK): Development of Phosphoacceptor Peptides for the Assay of ALK Activity †

✍ Scribed by Donella-Deana, Arianna; Marin, Oriano; Cesaro, Luca; Gunby, Rosalind H.; Ferrarese, Anna; Coluccia, Addolorata M. L.; Tartari, Carmen J.; Mologni, Luca; Scapozza, Leonardo; Gambacorti-Passerini, Carlo; Pinna, Lorenzo A.

Book ID: 127008385
Publisher: American Chemical Society
Year: 2005
Tongue: English
Weight: 192 KB
Volume: 44
Category: Article
ISSN: 0006-2960
DOI: 10.1021/bi0472954

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of anaplastic lymphoma kinas

Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy

✍ Rongshi Li; Stephan W. Morris 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB

## Abstract Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) involved in the genesis of several human cancers; indeed, ALK was initially identified in constitutively activated and oncogenic fusion forms—the most common being nucleophosmin (NPM)‐ALK—in a non‐Hodgkin's lymphoma (N

ChemInform Abstract: Development of Anap

ChemInform Abstract: Development of Anaplastic Lymphoma Kinase (ALK) Small-Molecule Inhibitors for Cancer Therapy

✍ Rongshi Li; Stephan W. Morris 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 15 KB 👁 1 views

ALK (anaplastic lymphoma kinase, CD246)-

ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors

✍ Rimas J Orentas,Paola Lopomo,William Babbitt… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 73 KB

The Discovery and Optimization of a Nove

The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer

✍ Lewis, Richard T.; Bode, Christiane M.; Choquette, Deborah M.; Potashman, Michel 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 594 KB

[Annual Reports in Medicinal Chemistry]

[Annual Reports in Medicinal Chemistry] Annual Reports in Medicinal Chemistry Volume 47 Volume 47 || Anaplastic Lymphoma Kinase Inhibitors for the Treatment of ALK-Positive Cancers

✍ Kinoshita, Kazutomo 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 428 KB

The tyrosine kinase NPM-ALK, associated

The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation

✍ Gabriele Hübinger; Inka Scheffrahn; Elke Müller; Renyuan Bai; Justus Duyster; St 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 857 KB